{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:29:13Z","timestamp":1786649353871,"version":"build-2736575974"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T00:00:00Z","timestamp":1740614400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Mucormycosis, caused by filamentous fungi, is a rare but potentially fatal fungal infection associated with high morbidity and mortality. The COVID-19 pandemic has brought renewed attention to this infection, with an increasing number of cases worldwide. To study the clinico-demographic characteristics and their association with outcomes in mucormycosis cases. A tertiary care government hospital in Western Maharashtra. A Descriptive Cross-Sectional study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methodology:<\/jats:title>\n                    <jats:p>The study was conducted in a tertiary care hospital analyzing information from all cases of mucormycosis admitted between January 2021 and December 2022. Data were collected from the medical record section encompassing demographic details, clinical features, treatment, and outcome. Proportion, standard deviation, Chi-square test were used to analyze data by using Microsoft Excel.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Demographic analysis revealed a predominance of males 66.67%, and rural residents 73.53% among the mucormycosis cases. Co-morbidities were prevalent in 71.57% cases. The most common clinical presentation was rhino-orbital-cerebral mucormycosis (91.67%). Cortico-steroid use was seen in 58.82% cases. Among 270 cases, the case fatality rate was 24.45%. Older age, co-morbidities, COVID-19 status, delayed diagnosis, and delay in treatment were significantly associated with mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Demographic, clinical, and treatment-related factors influence mucormycosis outcome. Early diagnosis, aggressive treatment, and management of co-morbidities can mitigate morbidity and mortality associated with mucormycosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijcm.ijcm_137_24","type":"journal-article","created":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T03:00:43Z","timestamp":1741316443000},"page":"663-668","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["A Clinico-Demographic Study of Mucormycosis Cases Admitted in a Tertiary Care Government Hospital in Western Maharashtra"],"prefix":"10.4103","volume":"50","author":[{"given":"MS","family":"Anitha","sequence":"first","affiliation":[{"name":"Department of Medicine, Dr. V.M. Government Medical College, Solapur, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sagar Mitrajit","family":"Gaikwad","sequence":"additional","affiliation":[{"name":"Department of Community Medicine, Dr. V.M. Government Medical College, Solapur, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gajanan M.","family":"Jatti","sequence":"additional","affiliation":[{"name":"Department of Community Medicine, Dr. V.M. Government Medical College, Solapur, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lagdir L.","family":"Gaikwad","sequence":"additional","affiliation":[{"name":"Department of Community Medicine, Dr. V.M. Government Medical College, Solapur, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hemlata G.","family":"Rokade","sequence":"additional","affiliation":[{"name":"Department of Community Medicine, Government Medical College, Dharashiv, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wasim A.","family":"Bennishirur","sequence":"additional","affiliation":[{"name":"Department of Community Medicine, Dr. V.M. Government Medical College, Solapur, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,2,27]]},"reference":[{"issue":"Suppl 1","key":"R1-20260421","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1093\/mmy\/myx101","article-title":"Challenges in the diagnosis and treatment of mucormycosis","volume":"56","author":"Skiada","year":"2018","journal-title":"Med Mycol"},{"key":"R2-20260421","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1086\/432579","article-title":"Epidemiology and outcome of zygomycosis: A review of 929 reported cases","volume":"41","author":"Roden","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R3-20260421","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1186\/1471-2334-14-310","article-title":"Hospital days, hospitalization costs, and inpatient mortality among patients with mucormycosis: A retrospective analysis of US hospital discharge data","volume":"14","author":"Zilberberg","year":"2014","journal-title":"BMC Infect Dis"},{"key":"R4-20260421","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1111\/j.1469-0691.2010.03456.x","article-title":"Zygomycosis in Europe: Analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007","volume":"17","author":"Skiada","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"R5-20260421","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.dsx.2021.04.024","article-title":"Resurgence of COVID-19 and diabetes in India","volume":"15","author":"Pal","year":"2021","journal-title":"Diabetes Metab Syndr"},{"key":"R6-20260421","doi-asserted-by":"crossref","first-page":"102146","DOI":"10.1016\/j.dsx.2021.05.019","article-title":"Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India","volume":"15","author":"Singh","year":"2021","journal-title":"Diabetes Metab Syndr"},{"key":"R7-20260421","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3390\/jof5010026","article-title":"Global epidemiology of mucormycosis","volume":"5","author":"Prakash","year":"2019","journal-title":"J Fungi (Basel)"},{"key":"R8-20260421","doi-asserted-by":"crossref","first-page":"e543","DOI":"10.1016\/S2666-5247(21)00237-8","article-title":"The emergence of COVID-19 associated mucormycosis: A review of cases from 18 countries","volume":"3","author":"Hoenigl","year":"2022","journal-title":"Lancet Microbe"},{"key":"R9-20260421","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00251-021-01226-5","article-title":"Black fungus immunosuppressive epidemic with Covid-19 associated mucormycosis (zygomycosis): A clinical and diagnostic perspective from India","volume":"74","author":"Singh","year":"2022","journal-title":"Immunogenetics"},{"key":"R10-20260421","first-page":"11","article-title":"Mucormycosis and Covid-19: Risk factors, clinical presentation and outcome in a tertiary care centre in north India","volume":"70","author":"A","year":"2022","journal-title":"J Assoc Physicians India"},{"key":"R11-20260421","doi-asserted-by":"crossref","first-page":"535","DOI":"10.4103\/ijd.ijd_17_22","article-title":"COVID-19 and mucormycosis: A black fungus disaster?","volume":"67","author":"Chillana","year":"2022","journal-title":"Indian J Dermatol"},{"key":"R12-20260421","doi-asserted-by":"crossref","first-page":"6107","DOI":"10.4103\/jfmpc.jfmpc_291_22","article-title":"Mucormycosis and diabetes in the times of COVID-19: A Mumbai-based observational study","volume":"11","author":"Hinduja","year":"2022","journal-title":"J Family Med Prim Care"},{"key":"R13-20260421","doi-asserted-by":"crossref","first-page":"100424","DOI":"10.1016\/j.ijmmb.2023.100424","article-title":"Isolate profiling and geographical distribution of COVID-19 associated mucormycosis cases presenting to a tertiary care hospital in Jodhpur, India","volume":"46","author":"Twishi","year":"2023","journal-title":"Indian J Med Microbiol"},{"key":"R14-20260421","doi-asserted-by":"crossref","first-page":"e405","DOI":"10.1016\/S1473-3099(19)30312-3","article-title":"Global guideline for the diagnosis and management of mucormycosis: An initiative of the european confederation of medical mycology in cooperation with the mycoses study group education and research consortium","volume":"19","author":"Cornely","year":"2019","journal-title":"Lancet Infect Dis"},{"issue":"Suppl 1","key":"R15-20260421","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1093\/cid\/cir880","article-title":"A global analysis of mucormycosis in France: The RetroZygo study (2005-2007)","volume":"54","author":"Lanternier","year":"2012","journal-title":"Clin Infect Dis"},{"key":"R16-20260421","doi-asserted-by":"crossref","first-page":"492","DOI":"10.3324\/haematol.2012.065110","article-title":"Diagnosis and treatment of mucormycosis in patients with hematological malignancies: Guidelines from the 3rd european conference on infections in leukemia (ECIL 3)","volume":"98","author":"Skiada","year":"2013","journal-title":"Haematologica"}],"container-title":["Indian Journal of Community Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijcm.ijcm_137_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T18:52:59Z","timestamp":1786647179000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijcm.ijcm_137_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,27]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/ijcm.ijcm_137_24","relation":{},"ISSN":["0970-0218","1998-3581"],"issn-type":[{"value":"0970-0218","type":"print"},{"value":"1998-3581","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,27]]},"assertion":[{"value":"2024-03-07","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-05","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}